Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,022.00
Ask: 12,026.00
Change: 672.00 (5.92%)
Spread: 4.00 (0.033%)
Open: 11,890.00
High: 12,086.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK PM Warns Of Tougher Measures Ahead, Calls For "Maximum Vigilance"

Mon, 11th Jan 2021 16:25

(Alliance News) - UK Prime Minister Boris Johnson has warned that tougher lockdown measures may be needed as he announced that around 2.4 million vaccines for Covid-19 have now been put in people's arms in the UK.

The prime minister stressed "now is the moment for maximum vigilance" amid increasing calls for tougher lockdown restrictions as case rates soar in several parts of the country.

During a visit to a vaccine centre in Ashton Gate Stadium, Bristol, the prime minister said: "We're going to keep the rules under constant review.

"Where we have to tighten them, we will.

"We have rules in place already which, if they are properly followed, we believe can make a huge, huge difference.

"It's now that people need to focus...when they're out shopping, whether they're buying cups of coffee in the park or whatever it happens to be, they need to think about spreading the disease."

Johnson said that "more important than us just pushing out new rules", people should follow existing guidance.

"In supermarkets, people need to be keeping their distance, making sure that they're wearing masks, doing the right thing.

"We need to enforce the rules in supermarkets. When people are getting takeaway drinks, in cafes, then they need to avoid spreading the disease there, avoid mingling too much.

"Now is the moment for maximum vigilance, maximum observance of the rules.

"Of course, if we feel that things are not being properly observed then we may have to do more."

Turning to vaccines, the prime minister said roughly 40% of the 80-year-olds in the UK have now been vaccinated, with around 23% of the elderly residents of care homes having been inoculated.

He said around two million people overall have received a vaccine and "maybe a bit more".

He added: "We're at about 2.4 million jabs all in across the whole of the UK."

Among those calling for tougher lockdown rules is Labour leader Keir Starmer, who told reporters the country is "at the most serious stage" of the pandemic "and that calls for the most serious restrictions".

Starmer said: "There probably is more that we could do.

"An example is the question of whether nurseries should be open."

It comes as Chris Whitty, England's chief medical officer, warned the UK has not yet hit the peak of the current wave of Covid-19 infections, with the next few weeks being "the worst" of the pandemic for the NHS.

He said the vaccine rollout offered hope that lockdown restrictions could be lifted in the coming months but described the current UK death and case rate as an "appalling situation".

During a BBC phone-in on the current high case rates, he said: "I don't think we're yet at the peak, I'm afraid.

"I think we will be at the peak if everybody can double down and absolutely minimise their contacts.

"The point of the lockdown is to bring that forward, but it only works if everyone really thinks about every individual interaction they have and try and minimise them."

Whitty said the new variant of coronavirus was causing a "significant problem", telling BBC Breakfast: "We will get through together but at this point in time we're at the worst point in the epidemic for the UK."

Currently, around one in 50 people in England is infected.

Whitty said: "There's a very high chance that if you meet someone unnecessarily they will have Covid."

He added: "This is the most dangerous time we have really had in terms of numbers into the NHS at this particular time."

Asked if coronavirus is being spread outdoors, Whitty said the risks were much lower than for indoors, but said problems could occur if people gathered in groups, such as huddled round a market stall.

Pressed on whether people should wear masks in all outdoor settings, he said the most important thing was actually that people stayed home unless their journey was essential.

"I think that the much more important thing is that people should not be leaving their home unless they absolutely have to," he said.

"And where they do, try and keep their distance from people."

He added: "In a sense tinkering with the rules may be useful, but the far more important thing is that everybody abides by the spirit of the rules that are there at the moment."

It comes as seven mass vaccination centres open across England in a drive to ramp up the rollout of coronavirus vaccines from Pfizer Inc and AstraZeneca PLC.

The government aims to hit a target of vaccinating around 15 million people at highest risk of death and severe disease by the middle of February.

The new centres – including at a football stadium and a tennis club – will be joined later this week by hundreds more GP-led and hospital services along with the first pharmacy-led pilot sites, taking the total in England to around 1,200.

Overall there will be 2,700 vaccine sites across the UK, according to the government vaccine rollout plan.

The document sets out plans to vaccinate at least two million people a week, with ministers pledging that "tens of millions will be immunised by spring".

It also suggests that "those delivering key public services" and others at high risk of exposure could be next in line for the vaccine once the at-risk priority groups have been vaccinated.

By Jane Kirby, PA Health Editor

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
Today 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
Today 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
Today 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
Today 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
Today 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
Today 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.